ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,233,301 | +2974.8% | 474,376 | +2848.4% | 0.01% | – |
| Q2 2023 | $202,721 | +48.4% | 16,089 | +53.7% | 0.00% | – |
| Q1 2023 | $136,594 | -99.3% | 10,467 | -99.2% | 0.00% | -100.0% |
| Q3 2022 | $19,586,000 | +1003.4% | 1,286,015 | +974.5% | 0.03% | +1033.3% |
| Q2 2022 | $1,775,000 | -34.1% | 119,685 | +0.0% | 0.00% | -25.0% |
| Q1 2022 | $2,694,000 | +22.3% | 119,646 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $2,203,000 | +37.5% | 119,386 | -0.4% | 0.00% | +33.3% |
| Q3 2021 | $1,602,000 | -27.8% | 119,828 | -0.1% | 0.00% | -25.0% |
| Q2 2021 | $2,220,000 | +23.3% | 119,938 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,801,000 | -2.1% | 119,938 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $1,840,000 | +77.4% | 127,424 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $1,037,000 | +20.2% | 127,424 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $863,000 | -3.8% | 127,424 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $897,000 | +253.1% | 127,424 | +451.5% | 0.00% | +200.0% |
| Q3 2019 | $254,000 | -5.6% | 23,103 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $269,000 | +36.5% | 23,103 | +11.9% | 0.00% | 0.0% |
| Q1 2019 | $197,000 | -45.9% | 20,643 | -45.4% | 0.00% | 0.0% |
| Q4 2018 | $364,000 | -29.6% | 37,793 | +4.1% | 0.00% | -50.0% |
| Q3 2018 | $517,000 | +82.0% | 36,293 | +53.5% | 0.00% | +100.0% |
| Q2 2018 | $284,000 | -23.7% | 23,643 | -21.6% | 0.00% | -50.0% |
| Q1 2018 | $372,000 | +1590.9% | 30,149 | +1671.4% | 0.00% | – |
| Q2 2017 | $22,000 | +4.8% | 1,702 | +1.4% | 0.00% | – |
| Q1 2017 | $21,000 | -82.1% | 1,678 | -85.4% | 0.00% | -100.0% |
| Q4 2016 | $117,000 | +192.5% | 11,507 | +276.5% | 0.00% | – |
| Q3 2016 | $40,000 | +48.1% | 3,056 | +45.4% | 0.00% | – |
| Q2 2016 | $27,000 | -3.6% | 2,102 | 0.0% | 0.00% | – |
| Q1 2016 | $28,000 | +12.0% | 2,102 | +31.2% | 0.00% | – |
| Q4 2015 | $25,000 | +25.0% | 1,602 | -2.1% | 0.00% | – |
| Q3 2015 | $20,000 | +11.1% | 1,637 | +9.1% | 0.00% | – |
| Q1 2015 | $18,000 | -10.0% | 1,500 | -6.2% | 0.00% | – |
| Q4 2014 | $20,000 | -16.7% | 1,600 | -11.1% | 0.00% | – |
| Q3 2014 | $24,000 | -72.4% | 1,800 | -66.7% | 0.00% | -100.0% |
| Q2 2014 | $87,000 | -10.3% | 5,411 | +0.2% | 0.00% | 0.0% |
| Q1 2014 | $97,000 | +212.9% | 5,400 | +170.0% | 0.00% | 0.0% |
| Q4 2013 | $31,000 | +14.8% | 2,000 | +11.1% | 0.00% | 0.0% |
| Q3 2013 | $27,000 | +17.4% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $23,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |